Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

US Patent 9061031 · Granted Jun 23, 2015

Estimated economic value: $120,500,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oncolytic viral vectors and uses thereof2025
Oncolytic viral delivery of therapeutic polypeptides2024
Compositions and methods for selective elimination and replacement of hematopoie2023
Oncolytic viral vectors and uses thereof2023
Oncolytic viral vectors and uses thereof2022
Vectors and compositions for treating hemoglobinopathies2022
Oncolytic viral delivery of therapeutic polypeptides2021
Oncolytic viral vectors and uses thereof2019
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2017
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2017
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2017
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2017